A healthcare employee prepares a syringe with the Moderna Covid-19 vaccine at the Dennis Avenue Health Center in Silver Spring, Maryland, on 21 November 2022. he Washington Post/Getty ImagesA healthcare employee prepares a syringe with the Moderna Covid-19 vaccine at the Dennis Avenue Health Center in Silver Spring, Maryland, on 21 November 2022. he Washington Post/Getty ImagesUS health officials re-examine RSV shots despite documented safety and efficacyThe FDA is reviewing RSV vaccines, which have drastically lowered infant hospitalizations, a spokesperson confirmedUS regulatory officials are re-examining the safety of RSV shots despite no published reports of safety issues – a move that could lead to the removal or limitation of shots that have dramatically lowered hospitalizations among babies. It’s the latest move from US health officials under Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services (HHS) and a longtime anti-vaccine activist, to limit access to shots and to undermine public trust in the safe and effective products. Officials at the US Food and Drug Administration (FDA) told three manufacturers of RSV preventative treatments for babies last week their products are being reviewed because of safety concerns raised by anti-vaccine activists, Reuters reported on Tuesday. Experts fear for US childhood vaccine schedule after hepatitis B guideline changeRead moreWhen asked by the Guardian if the FDA was reviewing the preventative shots and maternal RSV shots, a spokesperson confirmed the news. The FDA routinely evaluates safety information about approved drugs, HHS press secretary Emily Hilliard said.
